DENVER, Feb. 10, 2006 (PRIMEZONE) -- Chelsea Management Group Inc. (Other OTC:CLMP) has successfully completed an agreement with Ultra Herbal LLC to market, distribute and promote two products -- a natural pain reliever and a natural sleep aid.
Eazol may relieve chronic pain of osteoarthritis, rheumatism, neuralgia, stiff joints, shingles, neck ache, and lower back pain. Eazol can also provide pain relief from carpal tunnel syndrome, tendonitis, fibromyalgia, muscle and joint pain, pinched nerves and sprains. Eazol(tm) is the only pain relief health supplement that includes a complete list of active botanicals in one easy to take supplement.
Melatrol Natural Sleep Aid helps in relaxation, combats stress, has no known side effects, no prescription required and helps stimulate the sleep process. Melatrol is an ideal natural supplement to combat insomnia.
The two new products are an addition to our cyber distribution outlets and direct marketing programs under Chelsea Life Sciences Wellness Center division. Our current cyber outlet is located at www.wellnessbegins.com. "Our intention is to build an exclusive outlet for marketing Eazol and Melatrol," stated Peter Johansen, senior vice president of Chelsea.
Chelsea Management Group is a start-up and early-stage venture capital firm focused on the health and life sciences industry. Formed in 2001, CHELSEA searches for the winners of tomorrow -- entrepreneurs whose ideas and talents qualify them to pursue large market opportunities successfully. We seek opportunities across a broad spectrum including biotechnology and pharmaceuticals, medical devices, services and healthcare/life sciences information technology. On a selective basis, we also consider later-stage health and life sciences investments where we can uniquely apply Chelsea's industry and capital markets experience.
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e. future operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.